Discharge BNP is a stronger predictor of 6-month mortality in acute heart failure compared with baseline BNP and admission-to-discharge percentage BNP reduction

International Journal of Cardiology

Volumn 221, Issue , 2016, Pages 1116-1122

  Omar, Hesham R ^a   Guglin, Maya ^b  

^a Mercy Medical Center   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

B type natriuretic peptide; Heart failure; Mortality; Rehospitalization

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ACUTE HEART FAILURE; ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY RISK; PRIORITY JOURNAL; PROTEIN DETERMINATION; SURVIVAL PREDICTION; ACUTE DISEASE; BLOOD; DIMENSIONAL MEASUREMENT ACCURACY; EPIDEMIOLOGY; HEART FAILURE; HOSPITAL READMISSION; MORTALITY; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ACUTE DISEASE; DIMENSIONAL MEASUREMENT ACCURACY; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PATIENT DISCHARGE; PATIENT READMISSION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; UNITED STATES;

EID: 84979086195     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.07.117     Document Type: Article

References (25)

1. [1] Ambrosy, A.P., Fonarow, G.C., Butler, J., Chioncel, O., Greene, S.J., Vaduganathan, M., et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J. Am. Coll. Cardiol. 63:12 (Apr 1 2014), 1123–1133.
2. [2] Cooper, L.B., Mentz, R.J., Stevens, S.R., Felker, G.M., Lombardi, C., Metra, M., Hemodynamic predictors of heart failure morbidity and mortality: fluid or flow?. J. Card. Fail. 22:3 (Mar 2016), 182–189.
3. [3] Chen, H.H., Burnett, J.C., Natriuretic peptides in the pathophysiology of congestive heart failure. Curr. Cardiol. Rep. 2 (2000), 198–205.
4. [4] Doust, J.A., Pietrzak, E., Dobson, A., Glasziou, P., How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ, 330(7492), Mar 19 2005, 625.
5. [5] Bettencourt, P., Azevedo, A., Pimenta, J., Friões, F., Ferreira, S., Ferreira, A., N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 110:15 (2004 Oct 12), 2168–2174.
6. [6] Latini, R., Masson, S., Wong, M., Barlera, S., Carretta, E., Staszewsky, L., Incremental prognostic value of changes in B-type natriuretic peptide in heart failure. Am. J. Med., 119(1), Jan 2006 70.e23–30.
7. [7] Naffaa, M., Makhoul, B.F., Tobia, A., Jarous, M., Kaplan, M., Aronson, D., Brain natriuretic peptide at discharge as a predictor of 6-month mortality in acute decompensated heart failure. Am. J. Emerg. Med. 32:1 (Jan 2014), 44–49.
8. [8] Logeart, D., Thabut, G., Jourdain, P., Chavelas, C., Beyne, P., Beauvais, F., Predischarge B-type natriuretic peptide assay for identifying patients at high risk of readmission after decompensated heart failure. J. Am. Coll. Cardiol. 43:4 (Feb 18 2004), 635–641.
9. [9] Fonarow, G.C., Peacock, W.F., Phillips, C.O., Givertz, M.M., Lopatin, M., ADHERE scientific advisory committee and investigators, Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J. Am. Coll. Cardiol. 49:19 (May 15 2007), 1943–1950.
10. [10] Di Somma, S., Magrini, L., Pittoni, V., Marino, R., Mastrantuono, A., Ferri, E., In-hospital percentage BNP reduction is highly predictive for adverse events in patients admitted for acute heart failure: the Italian RED study. Crit. Care, 14(3), 2010, R116.
11. [11] Binanay, C., Califf, R.M., Hasselblad, V., O'Connor, C.M., Shah, M.R., Sopko, G., et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA 294 (2005), 1625–1633.
12. [12] Hanley, J.A., McNeil, B.J., A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148 (1983), 839–843.
13. [13] Omar, H.R., Guglin, M., A single BNP measurement in acute heart failure does not reflect the degree of congestion. J. Crit. Care, 8, Mar 2016.
14. [14] O'Connor, C.M., Hasselblad, V., Mehta, R.H., Tasissa, G., Califf, R.M., Fiuzat, M., Triage after hospitalization with advanced heart failure: the ESCAPE (evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness) risk model and discharge score. J. Am. Coll. Cardiol. 55:9 (Mar 2 2010), 872–878.
15. [15] Gackowski, A., Isnard, R., Golmard, J.L., Pousset, F., Carayon, A., Montalescot, G., Hulot, J.S., Thomas, D., Piwowarska, W., Komajda, M., Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure. Eur. Heart J. 25 (2004), 1763–1764, 10.1016/j.ehj.2004.07.038.
16. [16] Gustafsson, F., Torp-Pedersen, C., Seibaek, M., Burchardt, H., Køber L; DIAMOND study group. Effect of age on short and long-term mortality in patients admitted to hospital with congestive heart failure. Eur. Heart J. 25:19 (Oct 2004), 1711–1717.
17. [17] Waring, M.E., Saczynski, J.S., McManus, D., Zacharias, M., Lessard, D., Gore, J.M., Weight and mortality following heart failure hospitalization among diabetic patients. Am. J. Med. 124:9 (Sep 2011), 834–840.
18. [18] Aronson, D., Mittleman, M.A., Burger, A.J., Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure. Am. J. Med. 116:7 (Apr 1 2004), 466–473.
19. [19] Klein, L., Massie, B.M., Leimberger, J.D., O'Connor, C.M., Piña, I.L., Adams, K.F. Jr., Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the outcomes of a prospective trial of intravenous Milrinone for exacerbations of chronic heart failure (OPTIME-CHF). Circ. Heart Fail. 1:1 (May 2008), 25–33.
20. [20] Abraham, W.T., Fonarow, G.C., Albert, N.M., Stough, W.G., Gheorghiade, M., Greenberg, B.H., Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF). J. Am. Coll. Cardiol. 52:5 (Jul 29 2008), 347–356.
21. [21] Meijers, W.C., Hoekstra, T., Jaarsma, T., van Veldhuisen, D.J., de Boer, R.A., Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides. Neth. Hear. J. 24:4 (2016 Apr), 287–295.
22. [22] Omar, H.R., Acute cardiogenic pulmonary edema with normal BNP: the value of repeat BNP testing. Am. J. Emerg. Med., 33(4), Apr 2015 605.e5–6.
23. [23] Jourdain, P., et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP multicenter study. J. Am. Coll. Cardiol. 49 (2007), 1733–1739.
24. [24] Abraham, W.T., Adamson, P.B., Bourge, R.C., Aaron, M.F., Costanzo, M.R., Stevenson, L.W., et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet 377:9766 (Feb 19 2011), 658–666.
25. [25] Costanzo, M.R., Stevenson, L.W., Adamson, P.B., Desai, A.S., Heywood, J.T., Bourge, R.C., Bauman, J., Abraham, W.T., Interventions linked to decreased heart failure hospitalizations during ambulatory pulmonary artery pressure monitoring. JACC Heart Fail. 4:5 (2016 May), 333–344.